QUOTE AND NEWS
Benzinga  Mar 14  Comment 
Liberty Media (NASDAQ: LMCA) soared 8.53% to $136.90 in the pre-market trading after the company dropped its bid to buy SiriusXM (NASDAQ: SIRI). The company will reclassify common stock to create two groups. Ulta Salon, Cosmetics & Fragrance...
StreetInsider.com  Mar 7  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Achillion+Pharmaceuticals%2C+Inc.+%28ACHN%29+Posts+Q4+Loss+of+14cShare/9257969.html for the full story.
TheStreet.com  Mar 4  Comment 
NEW YORK (TheStreet) -- It would be a gross understatement to say that Achillion Pharmaceuticals has gone through some aches and pains. After Achillion traded as high as $10.17 in February of last year, the stock tanked to $2.26 in October --...
Benzinga  Jan 13  Comment 
Achillion Pharmaceuticals (Nasdaq: ACHN) today reported progress on the Company's portfolio of proprietary compounds for the treatment of chronic hepatitis C (HCV) and outlined its 2014 milestones. "We believe that we have the broad portfolio...
SeekingAlpha  Dec 11  Comment 
Achillion Pharmaceuticals, Inc. (ACHN) Oppenheimer 24th Annual Healthcare Conference Transcript December 11, 2013 01:35 p.m. ET Executives Milind Deshpande – President & CEO Analysts David Ferreiro – Biotech Analyst...
SeekingAlpha  Dec 4  Comment 
Achillion Pharmaceuticals, Inc. (ACHN) Piper Jaffray Healthcare Conference December 4, 2013 12:00 p.m. ET Executives Milind Deshpande - President and CEO Mary Kay Fenton - SVP & CFO Analysts Ed Tenthoff - Piper Jaffray ...
DailyFinance  Dec 2  Comment 
NEW YORK, NY -- (Marketwired) -- 12/02/13 -- Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Connecticut on behalf of investors who purchased Achillion...
Benzinga  Dec 2  Comment 
Camtek (NASDAQ: CAMT) surged 7.54% to $4.42 in the pre-market session. Camtek's PEG ratio is 2.99. Merrimack Pharmaceuticals (NASDAQ: MACK) shares gained 7.36% to $4.23 in the pre-market. Merrimack's trailing-twelve-month revenue is $54.15...
SeekingAlpha  Nov 25  Comment 
By Markus Aarnio: In this article, I will feature one biotech stock that has seen intensive insider buying during the last 30 days. Intensive insider buying can be defined by the following three criteria: The stock is purchased by three or...
TheStreet.com  Nov 25  Comment 
span.style4 {font-size: 10px; font-weight: bold; } span.style5 {font-size: 10px} By Jonathan Moreland, founder of Insider Insights and author of Profit From Legal Insider Trading. NEW YORK (TheStreet) -- It is a victory for common...





You may also be interested in articles related to Achillion Pharmaceuticals (ACHN):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki